Martin Redhead

Martin Redhead is Vice President Pharmacology at Recursion, where he leads efforts to integrate AI and computational approaches into drug discovery biology. With a career spanning academia and industry, Martin earned his PhD from the University of Nottingham before holding positions at Sygnature Discovery, UCB Pharma, and Exscientia. His work focuses on applying quantitative methods and artificial intelligence to accelerate the translation of biological insights into therapeutic candidates. At Recursion, Martin drives the development of innovative approaches that bridge computational biology, pharmacology, and AI-driven drug discovery platforms and heads up the UK discovery platform, an automated lab capable of completing full design, make, test learn loops for drug discovery projects.